Genovis AB is a Swedish life science company based in Lund that develops and supplies enzymes and reagents used in protein and antibody research. Its product range includes enzyme tools that help laboratories prepare, analyse and modify antibodies and other proteins. Customers are mainly pharmaceutical and biotechnology companies, contract research organisations and academic research laboratories that work with biopharmaceutical development and protein characterisation. The company also offers related services and products for laboratory workflows.
On this site Genovis AB (publ.) appears as a stock on the Nasdaq Stockholm (Sweden), code GENO, with prices in Swedish kronor (SEK). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #202 of 912 on the Nasdaq Stockholm · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Sweden yet.
TrendStrong
79/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average10.7%
From 52-week high-6.9%
MomentumFair
62/100
Typical recent returns for this exchange.
See the numbers →
3-month return7.7%
6-month return7.7%
12-month, skipping last month-18.2%
Stability (higher is calmer)Fair
66/100
Typical risk for this exchange.
See the numbers →
Volatility, 1 year (lower is calmer)40.0%
Worst drawdown, 1 year (smaller is calmer)-30.3%
LiquidityStrong
72/100
Trades actively.
See the numbers →
Avg daily value traded3.73M SEK
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Sweden when fundamentals data for this market is added. All Sweden stocks.
52-wk range 15.64 – 23.65Daily closes, split-adjusted
Signals
50-day average20.21
200-day average19.51
Golden/death cross (60d)Golden, 42 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.86
Technical summary
Daily
Strongly bullish
12 bullish · 1 neutral · 3 bearish
Weekly
Bullish
8 bullish · 1 neutral · 3 bearish
Monthly
Bearish
2 bullish · 1 neutral · 5 bearish
Moving averages (daily)
SMA 10
20.53
Bullish
EMA 10
20.66
Bullish
SMA 20
20.11
Bullish
EMA 20
20.33
Bullish
SMA 50
20.21
Bullish
EMA 50
20.09
Bullish
SMA 100
19.83
Bullish
EMA 100
19.96
Bullish
SMA 200
19.51
Bullish
EMA 200
20.23
Bullish
Oscillators (daily)
RSI (14)
64.35
Neutral
MACD (12, 26)
0.33
Bullish
Momentum (12)
6.40
Bullish
Stochastic %K (14)
86.30
Bearish
Williams %R (14)
-13.70
Bearish
CCI (20)
168.1
Bearish
Pivot points (classic, last session)
S3
20.18
S2
20.47
S1
21.03
Pivot
21.32
R1
21.88
R2
22.17
R3
22.73
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in SEK. Educational only, not financial advice.
